CSENGE ADVISORY GROUP – Eli Lilly and Company Transaction History
CSENGE ADVISORY GROUP portfolio value:
$1.30M
portfolio value
CSENGE ADVISORY GROUP quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.65% | 26 shares | 5K | $323.35 | 4.03K |
| Q2 2022 | share | Increase | +9.03% | 332 shares | 247K | $324.23 | 4.00K |
| Q1 2022 | share | Increase | +37.46% | 1.00K shares | 435K | $286.37 | 3.67K |
| Q4 2021 | share | Decrease | -38.22% | -1.65K shares | -376K | $277.25 | 2.67K |
| Q3 2021 | share | Increase | +61.87% | 1.65K shares | 376K | $230.3 | 4.33K |
| Q2 2021 | share | Decrease | -21.71% | -742 shares | -12K | $228.04 | 2.67K |
| Q1 2021 | share | Decrease | -38.76% | -2.16K shares | -312K | $184.81 | 3.41K |
| Q4 2020 | share | Decrease | -14.56% | -951 shares | 1K | $166.32 | 5.58K |
| Q3 2020 | share | Increase | +5.37% | 333 shares | -77K | $145.05 | 6.53K |
| Q2 2020 | share | Increase | +59.82% | 2.32K shares | 480K | $160.1 | 6.19K |
| Q1 2020 | share | Increase | +2.86% | 108 shares | 43K | $134.64 | 3.87K |
| Q4 2019 | share | Increase | +5.43% | 194 shares | 95K | $126.91 | 3.77K |
| Q3 2019 | share | Increase | 0.00% | 3.57K shares | 400K | $107.36 | 3.57K |
| Q1 2019 | share | Decrease | -100.00% | -1.82K shares | -211K | $123.17 | 0 |
| Q4 2018 | share | Increase | +245.75% | 1.3K shares | 153K | $109.26 | 1.82K |
| Q3 2018 | share | Increase | 0.00% | 529 shares | 58K | $100.8 | 529 |